Regeneron Pharmaceuticals ($REGN) Insider Trading & Smart Money Activity
Regeneron Pharmaceuticals, Inc. ($REGN) has 1 insider trade, 2 congress trades, 7 13F position changes and 5 analyst ratings on file. In the last 12 months on the open market, no insider bought and 1 insider sold ($3.20M), net -$3.20M.
- Insider buyers (12 mo)
- 0
- Insider sellers (12 mo)
- 1
- Net insider $ (12 mo)
- -$3.20M
- Congress trades (12 mo)
- 2
- 13F moves on file
- 7
- Analyst ratings on file
- 5
REGN insider buying and selling by quarter
| Quarter | Insider buys | Insider sales | Congress buys / sales | 13F added / cut |
|---|---|---|---|---|
| Q1 2026 | 0 | 0 | 1 / 0 | 0 / 0 |
| Q2 2026 | 0 | 0 | 0 / 1 | 0 / 3 |
| Q3 2026 | 0 | 0 | 0 / 0 | 0 / 0 |
| Q4 2026 | 0 | 1 · $3.20M | 0 / 0 | 2 / 2 |
Insider buys and sales count open-market trades only (Form 4 codes P and S). Grants, option exercises and tax withholding are left out.
All REGN insider, congress, 13F and analyst activity
| Date | Source | Who | Action | Shares | Value / amount | ΔOwn | 1W | 1M | 6M | Filing | Story |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 13F | Y-Intercept (Hong Kong) | Added | +22.64K sh | $19.60M | — | ||||||
| 13F | SteelPeak Wealth | Sold out | -21.94K sh | Read | |||||||
| 13F | Frank, Rimerman Advisors | Added | +876 sh | $1.10M | — | ||||||
| Analyst | UBS | Raises to Buy | PT $978 | Read | |||||||
| Insider | Murphy Andrew JCo-Chief Scientific Officer | Sell (Open-market sale) 10b5-1 | 4.15K sh | $3.20M | Read | ||||||
| 13F | Generate Investment Management | Reduced | -17.23K sh | $4.37M | — | ||||||
| Analyst | Truist Securities | Reiterates to Buy | PT $780 | +4.9% | — | ||||||
| Analyst | JP Morgan | Reiterates to Overweight | PT $950 | +1.9% | — | ||||||
| Analyst | Jefferies | Reiterates to Buy | PT $930 | +0.6% | — | ||||||
| Analyst | Argus Research | Raises to Buy | PT $850 | +0.6% | — | ||||||
| Congress | Gilbert Cisneros | Sale | $1,001 - $15,000 | -8.4% | -11.8% | Read | |||||
| 13F | Epoch Investment Partners | Reduced | -42.61K sh | $148.85M | -9.7% | -13.6% | — | ||||
| 13F | Dodge & Cox | Reduced | -138.12K sh | $2.72B | -9.7% | -13.6% | Read | ||||
| 13F | Dodge & Cox | Reduced | -138.12K sh | $2.78B | -9.7% | -13.6% | — | ||||
| Congress | Alan Armstrong | Purchase | $1,001 - $15,000 | +3.4% | +0.9% | +7.1% | — |
1W / 1M / 6M = how REGN moved from the trade or filing date.
Insider trading in REGN: who is buying and selling
| Insider | Role | Trades | Open-market net | Shares held | Last trade |
|---|---|---|---|---|---|
| Murphy Andrew J | Co-Chief Scientific Officer | 1 | -$3.20M | Oct 14, 2026 |
Members of Congress trading REGN
Institutions moving REGN (13F)
Analyst ratings on REGN
| Date | Firm | Action | Rating | Price target | 1W | 1M | 6M | Story |
|---|---|---|---|---|---|---|---|---|
| UBS | Raises | Buy | $660 → $978 | Read | ||||
| Truist Securities | Reiterates | Buy | $772 → $780 | +4.9% | — | |||
| JP Morgan | Reiterates | Overweight | $900 → $950 | +1.9% | — | |||
| Jefferies | Reiterates | Buy | $870 → $930 | +0.6% | — | |||
| Argus Research | Raises | Buy | $850 | +0.6% | — |
Frequently asked questions
Are REGN insiders buying or selling?
Over the last 12 months 0 insiders made 0 open-market purchases worth $0 and 1 insider made 1 open-market sale worth $3.20M, a net -$3.20M.
What is the latest insider trade in REGN?
Murphy Andrew J, Co-Chief Scientific Officer filed a sell (open-market sale) of 4.15K sh worth $3.20M on Oct 14, 2026.
Which members of Congress traded REGN?
2 disclosed trades by Gilbert Cisneros and Alan Armstrong. The latest was on May 15, 2026.
Which institutions changed their REGN positions?
Recent 13F filers moving the stock include Dodge & Cox, Y-Intercept (Hong Kong), SteelPeak Wealth, Frank, Rimerman Advisors and Generate Investment Management.
Other biotechnology stocks
Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.
Get a text when insiders, Congress or big funds trade a stock.
Free. Reply STOP anytime.